mRNA |
tivozanib |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
4e-06 |
mRNA |
Axitinib |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
1e-05 |
mRNA |
decitabine:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
1e-05 |
mRNA |
STF-31 |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
3e-05 |
mRNA |
BRD-K48477130 |
CTRPv2 |
pan-cancer |
AAC |
0.23 |
3e-05 |
mRNA |
BCL-LZH-4 |
CTRPv2 |
pan-cancer |
AAC |
0.22 |
5e-05 |
mRNA |
nelarabine |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
6e-05 |
mRNA |
Dasatinib |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0001 |
mRNA |
Doxorubicin |
gCSI |
pan-cancer |
AAC |
-0.19 |
0.0002 |
mRNA |
navitoclax:pluripotin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0002 |